Anavex Life Sciences Stock (NASDAQ: AVXL) stock price, news, charts, stock research, profile.
Open | $5.010 |
Close | $5.090 |
Volume / Avg. | 978.032K / 1.483M |
Day Range | 4.981 - 5.200 |
52 Wk Range | 4.480 - 10.450 |
Market Cap | $411.384M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 47 |
Short Interest | 25.02% |
Days to Cover | 17.09 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Anavex Life Sciences (NASDAQ: AVXL) through any online brokerage.
Other companies in Anavex Life Sciences’s space includes: Renovaro (NASDAQ:RENB), Humacyte (NASDAQ:HUMA), Celcuity (NASDAQ:CELC), Inozyme Pharma (NASDAQ:INZY) and PepGen (NASDAQ:PEPG).
The latest price target for Anavex Life Sciences (NASDAQ: AVXL) was reported by HC Wainwright & Co. on Wednesday, January 3, 2024. The analyst firm set a price target for 40.00 expecting AVXL to rise to within 12 months (a possible 698.40% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Anavex Life Sciences (NASDAQ: AVXL) is $5.01 last updated March 28, 2024 at 4:07 PM EDT.
There are no upcoming dividends for Anavex Life Sciences.
Anavex Life Sciences’s Q2 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Anavex Life Sciences.
Anavex Life Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.